Furthermore, in patients with concomitant CAD and PAD, the inflammatory markers of neutrophil myeloperoxidase content and plasma levels of interleukin-6 (IL-6) were associated with impaired endothelial function [62]. Here, IL6 is linked to peripheral arterial disease.